Now THAT’S a session worthy of a strong earnings season! The market has been folding its arms in response to solid quarterly numbers of late, but today each of the major indices jumped by 1% or more amid a tech rebound. We can thank good old Facebook for leading the way on Thursday, as the social media giant hasn’t lost a step in the wake of Cambridge Analytica and Mark Zuckerberg’s Congressional testimony. After the bell yesterday, the company blew past Zacks Consensus Estimates on both the top and bottom lines, which led to shares jumping more than 9% today. Backed up by Facebook, the NASDAQ had no problem ending its five-session losing streak on Thursday. It was easily the best-performing index of the Big 3 with a surge of 1.64% to 7118.7. Best of all, Amazon just reported tremendous profit growth after the bell today, so this index and the market in general could have another shot in the arm on Friday that would pave the way for a third straight week of gains. As of this writing, shares of AMZN are up about 6% after hours. Meanwhile, the S&P was up 1.04% to 2666.9. The Dow ended its own 5-day losing streak yesterday, and today it added another 0.99% to 24,322.3. In addition to the rebound in tech, stocks also benefited from the 10-year Treasury note falling back below 3%. "Earnings are finally helping the market like they were supposed to. Last week it seemed like everything was getting sold into and it didn’t matter what the numbers were. This week we see the fundamentals are moving the stocks via earnings and that is helping the market grind higher," said Jeremy in Counterstrike Today's Portfolio Highlights: Technology Innovators: Given today's rally in the tech space, Brian Bolan felt it was time to put some money to work. On Thursday, he picked up Citrix Systems (CTXS), a software name that reported a strong quarter last night. It beat on both the top and bottom lines while also guiding higher for next quarter and the full year. CTXS is still only a Zacks Rank #3 (Hold), but the editor feels that will improve shortly as the company hits “new highs after new highs”. Read the complete commentary for more on this new addition. Momentum Trader: The NASDAQ should recover nicely over the next couple of weeks, according to Dave. So Thursday provided a great opportunity for the editor to add a tech name. He picked up a 12.5% allocation in Mellanox (MLNX), a Zacks Rank #1 (Strong Buy) supplier of semiconductor-based, interconnect products. Shares are moving toward its 52-week high after a strong quarterly report, and Dave thinks it’s ready to break on through to new heights. The full write-up has more on this new addition. Surprise Trader: Over the past four quarters, SodaStream (SODA) has put together an average beat of 40.4%. Dave expects the streak to continue when it reports again next Wednesday, especially since it has a positive Earnings ESP of more than 6%. The editor added SODA on Thursday while also selling Allegheny Tech (ATI) for an approximately 6% profit. See the complete commentary for more on today's moves. Healthcare Innovators: The portfolio cashed in a couple of profits on Thursday, as Kevin sold Baxter (BAX) and BioTelemetry (BEAT) for returns of nearly 25% and 17%, respectively. Both companies had good quarterly reports, but the editor feels he can make bigger profits elsewhere. He thinks BAX will struggle to hold $70, while BEAT is suffering from a lack of enthusiasm in the investment community. By the way, HI also had the top performing stock of the day as Alexion Pharma (ALXN) jumped more than 14.5% after a strong quarter. Options Trader: "With the correction lows seemingly behind us, we should soon see the markets stage a real challenge to their all-time highs made in January. "But the first target for the S&P 500 is the 2,750 level (we closed at 2,667 yesterday). Once we can clear that hurdle (descending resistance line that dates back to late January’s all-time high), I’m expecting the pace of this rally to pick up significantly. "In spite of the market’s rough start at the beginning of the week, stocks have been nothing short of impressive since then. And that’s a testament to the underlying bullishness of this historic bull market." -- Kevin Matras Have a Good Evening, Jim Giaquinto Recommendations from Zacks' Private Portfolios: Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >> Zacks Investment Research